Drug discovery company developing optimized drugs using proprietary computational drug design platform

Sectors
Healthcare
Life Sciences
First Invested
2001
Early
Company Status
IPO/Acquired
NASDAQ: VTAE
Acquired by Allergan
Associated Team
Ali Behbahani, MD